Skip to content

Clinical trials

Completed Phase 4 Ocular Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Phase 4 Status: Completed Clear all

99 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20033
20041
20058
20067
20076
20088
20098
201010
201116
20125
20139
20144
20152
20163
20171
20181
20192
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed99

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research30
Allergan21
Glaukos Corporation5
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Pharmaceutical Research Network4
Aristotle University Of Thessaloniki2
Bp Consulting, Inc2
Laboratorios Poen2
Aerie Pharmaceuticals1
Alcon, a Novartis Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension99
Glaucoma, Open-Angle69
Glaucoma51
Eye Diseases6
Cardiovascular Diseases1
Dry Eye Syndromes1
Exfoliation Syndrome1
Fibrosis1
Hyperemia1
Hypertension1

Trials

Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.